A 3 1/2-year clinical evaluation of resorbable hydroxylapatite OsteoGen (HA Resorb) used for sinus lift augmentations in conjunction with the insertion of endosseous implants.
A clinical study is presented of two cases in which resorbable hydroxylapatite [OsteoGen (HA Resorb), Stryker, Inc., Kalamazoo, MI] was used for sinus augmentation and sinus floor elevations. The insertion of endosseous titanium implants was done at the time of the sinus elevations.
Wagner
J R
JR
D000540:Alveolar Ridge Augmentation / Q000379:methods*; D001751:Blade Implantation; D003094:Collagen; D015921:Dental Implants; D017886:Durapatite; D006801:Humans; D006882:Hydroxyapatites; D008297:Male; D008443:Maxillary Sinus / Q000601:surgery*; D008875:Middle Aged; D014081:Tooth Extraction
D015921:Dental Implants; D006882:Hydroxyapatites; D003094:Collagen; D017886:Durapatite